Save your place

Sign in to WhoBought

Please try again later.

Cytokinetics, Incorporated (CYTK) institutional ownership

Latest close $82.19 Jul 22, 2026
Market cap$7.6B 52-week range SectorHealthcare
Funds holding · Q1 2026
440
reported CYTK position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
248 buyers · 192 sellers

Cytokinetics, Incorporated (CYTK) price and institutional activity

Dates

Q1 2026

$0 bought by 248 investors
Avoro Capital Advisors LLCParadigm Biocapital Advisors LP +246 more
$0 sold by 192 investors
FMR LLCDeep Track Capital, LP +190 more
Bought Sold Totals per quarter; hover a bar for the names.

Cytokinetics, Incorporated (CYTK) institutional activity · 440

Investor Type Est. change Change Δ Own Date
Avoro Capital Advisors LLC · New
Change +3.3M Date Q1 2026
Avoro Capital Advisors LLC New· Q1 2026 +3.3M Q1 2026
FMR LLC · Reduced
Change −2.1M Δ Own −16.3% Date Q1 2026
FMR LLC Reduced· Q1 2026 −2.1M −16.3% Q1 2026
Deep Track Capital, LP · Reduced
Change −2.0M Date Q1 2026
Deep Track Capital, LP Reduced· Q1 2026 −2.0M Q1 2026
Paradigm Biocapital Advisors LP · New
Change +1.5M Date Q1 2026
Paradigm Biocapital Advisors LP New· Q1 2026 +1.5M Q1 2026
William Blair Investment Management, LLC · New
Change +1.1M Date Q1 2026
William Blair Investment Management, LLC New· Q1 2026 +1.1M Q1 2026
Balyasny Asset Management L.P. · New
Change +993K Date Q1 2026
Balyasny Asset Management L.P. New· Q1 2026 +993K Q1 2026
UBS Group AG · Added
Change +946K Date Q1 2026
UBS Group AG Added· Q1 2026 +946K Q1 2026
Norges · Exited
Change −807K Δ Own −100.0% Date Q1 2026
Norges Exited· Q1 2026 −807K −100.0% Q1 2026
Capital Research Global Investors · New
Change +771K Date Q1 2026
Capital Research Global Investors New· Q1 2026 +771K Q1 2026
Polar Capital Holdings PLC · Reduced
Change −761K Date Q1 2026
Polar Capital Holdings PLC Reduced· Q1 2026 −761K Q1 2026
Woodline Partners LP · Reduced
Change −648K Date Q1 2026
Woodline Partners LP Reduced· Q1 2026 −648K Q1 2026
Point72 Asset Management, L.P. · New
Change +626K Date Q1 2026
Point72 Asset Management, L.P. New· Q1 2026 +626K Q1 2026
Siren, L.L.C. · New
Change +614K Date Q1 2026
Siren, L.L.C. New· Q1 2026 +614K Q1 2026
D. E. Shaw & Co., Inc. · Added
Change +587K Δ Own +492.7% Date Q1 2026
D. E. Shaw & Co., Inc. Added· Q1 2026 +587K +492.7% Q1 2026
Logos Global Management LP · Added
Change +575K Date Q1 2026
Logos Global Management LP Added· Q1 2026 +575K Q1 2026
Data through Q1 2026 · filed Jun 4, 2026
15 of 440

Famous investor activity in Cytokinetics, Incorporated (CYTK)

Cytokinetics, Incorporated (CYTK) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Wysenski Nancy · Director Grant (A) $6K
Price $82.62 Qty 75 Owned 34K ΔOwn +0.2% Trade date Jul 15, 2026 Filed date Jul 16, 2026
Wysenski Nancy Director Grant (A) $82.62 75 $6K 34K +0.2% Jul 15, 2026 Jul 16, 2026
Wierenga Wendell · Director Grant (A) $6K
Price $82.62 Qty 75 Owned 36K ΔOwn +0.2% Trade date Jul 15, 2026 Filed date Jul 16, 2026
Wierenga Wendell Director Grant (A) $82.62 75 $6K 36K +0.2% Jul 15, 2026 Jul 16, 2026
Kaye Edward M. Md · Director Grant (A) $12K
Price $82.62 Qty 151 Owned 10K ΔOwn +1.5% Trade date Jul 15, 2026 Filed date Jul 16, 2026
Kaye Edward M. Md Director Grant (A) $82.62 151 $12K 10K +1.5% Jul 15, 2026 Jul 16, 2026
Henderson John T. · Director Grant (A) $22K
Price $82.62 Qty 272 Owned 78K ΔOwn +0.3% Trade date Jul 15, 2026 Filed date Jul 16, 2026
Henderson John T. Director Grant (A) $82.62 272 $22K 78K +0.3% Jul 15, 2026 Jul 16, 2026
Harrington Robert Arthur · Director Grant (A) $12K
Price $82.62 Qty 151 Owned 22K ΔOwn +0.7% Trade date Jul 15, 2026 Filed date Jul 16, 2026
Harrington Robert Arthur Director Grant (A) $82.62 151 $12K 22K +0.7% Jul 15, 2026 Jul 16, 2026
Daly James M. · Director Grant (A) $12K
Price $82.62 Qty 151 Owned 3K ΔOwn +4.7% Trade date Jul 15, 2026 Filed date Jul 16, 2026
Daly James M. Director Grant (A) $82.62 151 $12K 3K +4.7% Jul 15, 2026 Jul 16, 2026
Blum Robert I. · Director 2 operations −$615K
Price $82.02 Qty −8K Owned 378K Trade date Jul 13, 2026 Filed date Jul 14, 2026
Blum Robert I. Director 2 operations $82.02 −8K −$615K 378K Jul 13, 2026 Jul 14, 2026
Blum Robert I. · Director 2 operations 0
Price $10.60 Owned 187K Trade date Jul 13, 2026 Filed date Jul 14, 2026
Blum Robert I. Director 2 operations $10.60 0 187K Jul 13, 2026 Jul 14, 2026
Malik Fady Ibraham · Officer Sell −$303K
Price $86.62 Qty −4K Owned 154K ΔOwn −2.2% Trade date Jul 7, 2026 Filed date Jul 7, 2026
Malik Fady Ibraham Officer Sell $86.62 −4K −$303K 154K −2.2% Jul 7, 2026 Jul 7, 2026
Malik Fady Ibraham · Officer 2 operations 0
Price $7.80 Owned 37K Trade date Jul 7, 2026 Filed date Jul 7, 2026
Malik Fady Ibraham Officer 2 operations $7.80 0 37K Jul 7, 2026 Jul 7, 2026
Blum Robert I. · Director Sell −$637K
Price $84.92 Qty −8K Owned 378K ΔOwn −1.9% Trade date Jul 1, 2026 Filed date Jul 2, 2026
Blum Robert I. Director Sell $84.92 −8K −$637K 378K −1.9% Jul 1, 2026 Jul 2, 2026
Callos Andrew · Officer Sell −$1.3M
Price $85.80 Qty −15K Owned 59K ΔOwn −20.4% Trade date Jul 1, 2026 Filed date Jul 2, 2026
Callos Andrew Officer Sell $85.80 −15K −$1.3M 59K −20.4% Jul 1, 2026 Jul 2, 2026
Callos Andrew · Officer 2 operations 0
Price $23.26 Owned 24K Trade date Jul 1, 2026 Filed date Jul 2, 2026
Callos Andrew Officer 2 operations $23.26 0 24K Jul 1, 2026 Jul 2, 2026
Lee Sung · Officer Sell −$98K
Price $87.79 Qty −1K Owned 63K ΔOwn −1.7% Trade date Jul 1, 2026 Filed date Jul 2, 2026
Lee Sung Officer Sell $87.79 −1K −$98K 63K −1.7% Jul 1, 2026 Jul 2, 2026
Lee Sung · Officer 2 operations 0
Price $48.51 Owned 27K Trade date Jul 1, 2026 Filed date Jul 2, 2026
Lee Sung Officer 2 operations $48.51 0 27K Jul 1, 2026 Jul 2, 2026
15 of 116
15 of 116 Sign in to continue to older insider transactions.

Cytokinetics, Incorporated (CYTK) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
BlackRock Inc. 16.1M
% of shares outstanding 16.4% Filing date Jan 22, 2024
BlackRock Inc. 16.1M 16.4% Jan 22, 2024
Blackrock, Inc. 15.3M
% of shares outstanding 13.0% Filing date Nov 12, 2024
Blackrock, Inc. 15.3M 13.0% Nov 12, 2024
Vanguard Group Inc 11.8M
% of shares outstanding 10.0% Filing date Nov 12, 2024
Vanguard Group Inc 11.8M 10.0% Nov 12, 2024
FMR LLC 11.1M
% of shares outstanding 9.0% Filing date May 6, 2026
FMR LLC 11.1M 9.0% May 6, 2026
T. Rowe Price Investment Management, Inc. 9.7M
% of shares outstanding 8.2% Filing date Nov 14, 2024
T. Rowe Price Investment Management, Inc. 9.7M 8.2% Nov 14, 2024
Wellington Management Group LLP 6.5M
% of shares outstanding 6.7% Filing date Feb 8, 2024
Wellington Management Group LLP 6.5M 6.7% Feb 8, 2024
State Street Corp
% of shares outstanding 6.0% Filing date Jan 25, 2024
State Street Corp 6.0% Jan 25, 2024
Vanguard Capital Management LLC 6.4M
% of shares outstanding 5.2% Filing date Apr 29, 2026
Vanguard Capital Management LLC 6.4M 5.2% Apr 29, 2026
8 of 10

Cytokinetics, Incorporated (CYTK) ownership FAQ

Who owns CYTK?

440 reporting institutions disclosed CYTK position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.